CST-2032

N/A

Report date: 2022/11/14 10:41:43

NME

Base Information

Drug NameCST-2032

Drug Alias NameCST-2032

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionBeta-2 adrenergic receptor agonists

TargetsBeta-2 adrenergic receptor

Therapy Area/IndicationsCognitive DysfunctionDementiaParkinson Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesNew Zealand

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCognitive DysfunctionDementia

Inactive IndicationsParkinson Disease

ATC CodeN/A